At week 104, 77.1 percent of semaglutide-treated participants had achieved at least 5 percent weight loss, compared to only 34.4 percent of the placebo group
& Westermark, G
According to NICE guidance (NG28) , GLP-1 receptor agonists like semaglutide are recommended for specific patient groups when other treatments have not been sufficient
Initiate Your Weight Loss Journey Now Embark on your semaglutide weight loss journey seamlessly with Klinik in Brandon, Florida
Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes
Cluster 2 comprised constipation, dehydration, headache, diarrhea, dizziness, hypoglycemia, sweating, and jaundice